PURPOSE: To reveal the interaction between beta-Lapachone (beta-lap) and ionizing radiation in causing cell death in RKO human colon adenocarcinoma cells, and to elucidate the potential usefulness of combined beta-lap treatment and radiotherapy for cancer treatment. MATERIALS AND METHODS: The cytotoxicities of various treatments were determined in vitro using clonogenic and apoptotic cell death. The changes in cell cycle distribution were studied using flow cytometry and an in vitro kinase assay. The tumor growth was studied using RKO tumors grown s.c. in the hind leg BALB/c- nuslc nude mice. RESULTS: beta-Lap caused clonogenic cell death and rapid apoptosis in RKO cells in vitro, in a dose dependent manner. The repair of sublethal radiation damage was almost completely inhibited when cells were maintained in beta-lap during the interval between the two-dose irradiation. Flow cytometry study demonstrated that beta-lap induced apoptosis, independent of the cell cycle phase, and completely prohibited the induction of radiation-induced G2 arrest in irradiated cells. The prohibition of radiation-induced G2 arrest is unclear, but may be related to the profound suppression of the p53, p21 and cyclin B1-Cdc2 kinase activities observed in cells treated with beta-lap. The combination of beta-lap and radiation markedly enhanced the radiation-induced growth suppression of tumors. CONCLUSION: beta-Lap is cytotoxic against RKO cells, both in vitro and in vivo, and also sensitized cells to ionizing radiation by inhibiting sublethal radiation damage repair. beta-lap is potentially useful as a potent anti-cancer chemotherapy drug and potent radiosensitizer against cancer cells.
PURPOSE: To reveal the interaction between beta-Lapachone (beta-lap) and ionizing radiation in causing cell death in RKO humancolon adenocarcinoma cells, and to elucidate the potential usefulness of combined beta-lap treatment and radiotherapy for cancer treatment. MATERIALS AND METHODS: The cytotoxicities of various treatments were determined in vitro using clonogenic and apoptotic cell death. The changes in cell cycle distribution were studied using flow cytometry and an in vitro kinase assay. The tumor growth was studied using RKO tumors grown s.c. in the hind leg BALB/c- nuslc nude mice. RESULTS: beta-Lap caused clonogenic cell death and rapid apoptosis in RKO cells in vitro, in a dose dependent manner. The repair of sublethal radiation damage was almost completely inhibited when cells were maintained in beta-lap during the interval between the two-dose irradiation. Flow cytometry study demonstrated that beta-lap induced apoptosis, independent of the cell cycle phase, and completely prohibited the induction of radiation-induced G2 arrest in irradiated cells. The prohibition of radiation-induced G2 arrest is unclear, but may be related to the profound suppression of the p53, p21 and cyclin B1-Cdc2 kinase activities observed in cells treated with beta-lap. The combination of beta-lap and radiation markedly enhanced the radiation-induced growth suppression of tumors. CONCLUSION: beta-Lap is cytotoxic against RKO cells, both in vitro and in vivo, and also sensitized cells to ionizing radiation by inhibiting sublethal radiation damage repair. beta-lap is potentially useful as a potent anti-cancer chemotherapy drug and potent radiosensitizer against cancer cells.
Authors: Robert J Griffin; Brent W Williams; Robert Wild; Julie M Cherrington; Heonjoo Park; Chang W Song Journal: Cancer Res Date: 2002-03-15 Impact factor: 12.701
Authors: Heon Joo Park; Ki-Jung Ahn; Seung-Do Ahn; Eunkyung Choi; Sang Wook Lee; Brent Williams; Eun Jung Kim; Robert Griffin; Erik A Bey; William G Bornmann; Jinming Gao; Heon Jin Park; David A Boothman; Chang W Song Journal: Int J Radiat Oncol Biol Phys Date: 2005-01-01 Impact factor: 8.013
Authors: S Miyamoto; T T Huang; S Wuerzberger-Davis; W G Bornmann; J J Pink; C Tagliarino; T J Kinsella; D A Boothman Journal: Ann N Y Acad Sci Date: 2000 Impact factor: 6.499
Authors: Youzhi Li; Xiangao Sun; J Thomas LaMont; Arthur B Pardee; Chiang J Li Journal: Proc Natl Acad Sci U S A Date: 2003-02-21 Impact factor: 12.779
Authors: S M Planchon; S M Wuerzberger-Davis; J J Pink; K A Robertson; W G Bornmann; D A Boothman Journal: Oncol Rep Date: 1999 May-Jun Impact factor: 4.136
Authors: Ganji Purnachandra Nagaraju; Batoul Farran; Matthew Farren; Gayathri Chalikonda; Christina Wu; Gregory B Lesinski; Bassel F El-Rayes Journal: Cancer Date: 2020-05-08 Impact factor: 6.860
Authors: Muhammad Shaalan Beg; Xiumei Huang; Molly A Silvers; David E Gerber; Joyce Bolluyt; Venetia Sarode; Farjana Fattah; Ralph J Deberardinis; Matthew E Merritt; Xian-Jin Xie; Richard Leff; Daniel Laheru; David A Boothman Journal: J Surg Oncol Date: 2017-03-27 Impact factor: 2.885